EGFR Tyrosine Kinase Inhibitor (TKI) Combined With Concurrent or Sequential Chemotherapy for Patients With Advanced Lung Cancer and Gradual Progression After First-Line EGFR-TKI Therapy: A Randomized Controlled Study

Chang, Q; Xu, JL; Qiang, HP; Teng, JJ; Qian, JL; Lv, MF; Zhang, YW; Lou, YQ; Zhao, YZ; Zhong, RB; Han, BH; Chu, TQ

Chu, TQ (corresponding author), Huaihai West Rd 241, Shanghai, Peoples R China.

CLINICAL LUNG CANCER, 2021; 22 (3): E395